Trial Profile
Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Propranolol (Primary)
- Indications Haemangioma
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 06 Aug 2018 Results (n=45) published in the Pediatrics.
- 17 Dec 2016 Status changed from recruiting to completed.
- 26 Aug 2015 New trial record